# Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status

> **NCT02118376** · NA · UNKNOWN · sponsor: **Shanghai 10th People's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Exenatide

## Key facts

- **NCT ID:** NCT02118376
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02118376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02118376, "Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02118376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*